ICD vs. Pacemaker: How They Differ and Who Needs Which

A 68-year-old woman comes back to clinic six weeks after her device implant. She's healed well, the incision looks good, and she feels back to her usual self. But she's still confused. Her neighbor had a "pacemaker" put in last year, and her sister-in-law in Phoenix has a "defibrillator." She can't remember which one she got. She tells me, "Is mine going to shock me? Will it pace my heart? Do I have the same thing my neighbor has, or something different?"

I'm Dr. Damian Rasch, a cardiologist in Encinitas. The confusion my patient walked in with is one of the most common conversations I have in clinic. Pacemakers and ICDs (implantable cardioverter-defibrillators) get lumped together because they look similar on a chest X-ray, sit in similar pockets under the collarbone, and both involve leads in the heart. But they treat opposite problems. A pacemaker watches for the heart going too slow and gives it a small electrical nudge to keep it beating. An ICD watches for the heart going dangerously fast in the bottom chambers and delivers a shock to reset it. Some devices do both. This article walks through the differences, who gets which device, the newer leadless and subcutaneous options, and what living with one is actually like.

Two Different Problems, Two Different Devices

The cleanest way to understand the difference is to start with the two problems these devices solve. They're opposite ends of the rhythm spectrum.

Bradyarrhythmias are slow rhythms. The heart's natural electrical system fails to fire at a normal rate, or the signal gets blocked on its way from the upper chambers to the lower chambers. Patients feel tired, lightheaded, short of breath, or they faint. The treatment is a pacemaker that senses when the heart isn't firing on its own and delivers a small electrical pulse to make it beat. The pulse is so small you can't feel it.

Ventricular arrhythmias are fast, dangerous rhythms originating in the bottom chambers. Ventricular tachycardia (VT) is a rapid, organized rhythm coming from the ventricle, often 150 to 250 beats per minute. Ventricular fibrillation (VF) is a chaotic rhythm where the ventricles aren't really pumping at all. Both are life-threatening; without treatment within minutes, VF causes sudden cardiac death. The treatment is a defibrillator that delivers a strong shock to reset the heart. An ICD is the implanted version of the same defibrillator paramedics carry on the ambulance.

A pacemaker treats slow. An ICD treats fast. The same patient can have both problems and need a device that does both.

How a Pacemaker Works

A pacemaker has two jobs: sense and pace. It continuously monitors the heart's electrical activity through its lead or leads, and when it detects that the heart hasn't fired on its own within a programmed interval, it delivers a small electrical pulse to make the heart contract. The pulse is calibrated to be just strong enough to capture the myocardium and produce a beat. Patients don't feel it.

A traditional pacemaker has a small generator (about the size of a silver dollar) implanted in a pocket under the skin near the collarbone. From the generator, one or two leads thread through a vein into the right side of the heart and anchor to the heart muscle. A single-chamber pacemaker has one lead in the right ventricle. A dual-chamber pacemaker has one lead in the right atrium and one in the right ventricle, allowing the device to coordinate timing between upper and lower chambers (preserving the natural sequence of atrial contraction followed by ventricular contraction, which improves the heart's efficiency).

A pacemaker doesn't shock. The energy it delivers is in the milliJoule range, thousands of times smaller than what an ICD delivers. If a patient with a pacemaker develops VF, the pacemaker can't treat it.

Who Needs a Pacemaker

Pacemakers are placed for symptomatic bradyarrhythmias and for high-grade conduction disease where future symptoms are likely. The most common indications:

Complete heart block (third-degree AV block), where signals from the atrium fail to reach the ventricle. The ventricle relies on a slow escape rhythm, and patients are at risk for syncope and sudden death. Pacing is mandatory whether or not the patient is symptomatic.

Symptomatic Mobitz II second-degree AV block, where some atrial signals reach the ventricle and others don't, with no warning. This pattern often progresses to complete heart block, so pacing is recommended given the unpredictability of progression.

Sinus node dysfunction with symptoms. The sinus node, the heart's natural pacemaker in the right atrium, slows down or pauses inappropriately. When patients have documented bradycardia or pauses correlating with fatigue, lightheadedness, or syncope, pacing is appropriate.

Atrial fibrillation with slow ventricular response, where the AV node has slowed enough that the ventricular rate is too slow to maintain cardiac output. Some patients need rate-slowing medications but can't tolerate them because their baseline rate is already too slow; pacing lets us use the medications safely.

Syncope with documented bradycardia or pauses on ambulatory monitoring during the event. A patient who has a slow heart but no symptoms and no high-grade block doesn't necessarily need a pacemaker; the decision is driven by the combination of rhythm findings and symptoms.

Leadless Pacemakers: Micra AV and Micra VR

The traditional pacemaker design has been around for decades, and the leads going through veins into the heart have been a major source of long-term complications. Leads can fracture, dislodge, get infected, or develop insulation breaks. The pocket where the generator sits can erode or get infected.

Leadless pacemakers were designed to eliminate the lead and pocket altogether. The Micra (made by Medtronic) is a self-contained device about the size of a large vitamin capsule. It's delivered through a catheter inserted in the femoral vein, advanced up through the inferior vena cava, and anchored directly into the wall of the right ventricle. The whole device, generator and electrode together, sits inside the heart. No lead through the subclavian vein, no pocket under the collarbone, no incision near the chest.

The original Micra (now called Micra VR) paces only the right ventricle and senses only ventricular activity. It works well for patients with permanent or persistent atrial fibrillation who need ventricular pacing, where the lack of atrial-to-ventricular coordination doesn't matter because there's no organized atrial activity to coordinate with.

The Micra AV adds atrial sensing through accelerometer-based detection of atrial mechanical activity. The device infers when the atrium is contracting based on small movements that travel through the ventricle wall and times its ventricular pacing to follow that atrial signal. This restores AV synchrony in patients who have intact sinus node function but AV block. For many patients with AV block who would otherwise need a dual-chamber pacemaker, Micra AV is a reasonable alternative.

Leadless pacemakers don't work for everyone. They can't pace the atrium, so they're not used in patients who need atrial pacing for sinus node dysfunction. They have shorter battery lives than transvenous pacemakers. For the right patient, though, the absence of leads and pockets dramatically reduces long-term complications.

How an ICD Works

An ICD has all the same functions as a pacemaker plus one more: it can deliver high-energy shocks to terminate VT and VF. Every ICD is also a pacemaker. The reverse isn't true.

The generator looks similar to a pacemaker generator but is slightly larger to house the high-voltage capacitor needed for shocks. The right ventricular lead has a defibrillation coil along its length, which delivers the shock. When the device detects a sustained rapid ventricular rhythm meeting programmed criteria, it confirms the rhythm, charges the capacitor (5 to 15 seconds), and delivers a shock.

Modern ICDs try anti-tachycardia pacing (ATP) before shocking when possible. ATP is a burst of rapid pacing pulses delivered to the ventricle in an attempt to interrupt the reentrant circuit driving the VT. If the rhythm is monomorphic VT at a rate that allows ATP, the device tries it first. ATP is painless and terminates VT a substantial fraction of the time. If ATP fails, or if the rhythm is too fast or disorganized for ATP, the device shocks. Faster rhythms (above 220 to 240 beats per minute, in the VF zone) skip ATP and go straight to shock.

An ICD shock is described as a strong kick to the chest. It's painful but brief. After a shock, call your cardiologist the same day to confirm the device worked appropriately and to assess for arrhythmia triggers.

Who Needs an ICD: Primary Prevention

Primary prevention means putting an ICD in someone who's at high risk for sudden cardiac death but hasn't had a life-threatening arrhythmia yet. The decision is based on data from large randomized trials.

Ischemic cardiomyopathy with reduced ejection fraction is the most established indication. Patients with prior myocardial infarction, ejection fraction 35 percent or below, and NYHA class II or III symptoms benefit from primary prevention ICDs. The MADIT-II trial and SCD-HeFT established this. The risk reduction in mortality from ICD placement is meaningful, with absolute risk reductions in the range of 5 to 8 percent over several years of follow-up.

Non-ischemic cardiomyopathy with reduced ejection fraction has a more complicated story. Earlier observational data and SCD-HeFT (which included non-ischemic patients) supported ICD placement at the same EF threshold. The DANISH trial, published in 2016, randomized non-ischemic cardiomyopathy patients with EF 35 percent or below to ICD versus no ICD and found no mortality benefit overall, though the trial did show reduction in sudden cardiac death. Current guidelines still support ICD placement for non-ischemic patients meeting criteria, but the conversation with patients reflects this complexity. Younger patients and those with more clearly arrhythmic features are more likely to benefit.

Other primary prevention indications include inherited arrhythmia syndromes with high-risk features (long QT, hypertrophic cardiomyopathy, Brugada with prior syncope) and select patients with congenital heart disease and reduced ventricular function.

Who Needs an ICD: Secondary Prevention

Secondary prevention means putting an ICD in someone who has already had a life-threatening arrhythmia and survived. The risk of recurrence is high, and the benefit of an ICD is substantial.

Patients who have survived sudden cardiac arrest from VT or VF, without a clearly reversible cause, get ICDs. The exception is when the arrest was caused by something fixable (acute MI with successful revascularization, electrolyte abnormality, drug effect that's been removed); when the cause is fixable and well-treated, the recurrence risk drops and an ICD may not be needed. Patients with sustained VT, especially with structural heart disease, also get ICDs. Sustained VT carries a high risk of degeneration into VF and sudden death.

The data supporting secondary prevention ICDs goes back to the AVID, CIDS, and CASH trials in the 1990s, all of which showed mortality benefit over antiarrhythmic medication alone. Secondary prevention is one of the most clear-cut indications in cardiology.

Subcutaneous ICD (S-ICD)

The traditional ICD has a transvenous lead that goes through a vein into the right ventricle. Like all transvenous leads, it can fracture, dislodge, or develop infection that tracks back along the lead into the bloodstream. Lead-related complications are the most common reason for ICD reoperation.

The subcutaneous ICD (S-ICD) was designed to avoid the transvenous lead entirely. The generator sits in a pocket on the left side of the chest, and a single lead is tunneled under the skin along the sternum. There's no lead in the heart, no lead in any vein. Sensing happens through skin-surface electrodes, and shocks are delivered between the lead and the can.

The S-ICD shocks effectively but can't pace. It can't deliver bradycardia pacing, and it can't deliver anti-tachycardia pacing to terminate VT before shocking. Every VT or VF episode that meets shock criteria gets a shock. The S-ICD has found its strongest role in younger patients with channelopathies (long QT, Brugada) who need defibrillation but not pacing, and in patients with limited venous access, prior lead infections, or other reasons to avoid transvenous leads.

EV-ICD: The Newest Option

The extravascular ICD (EV-ICD) is the most recent addition to the ICD lineup. Approved by the FDA in 2023, it places the lead under the sternum (substernally), in the space between the breastbone and the heart, rather than through a vein. The generator sits in the standard left chest pocket.

The EV-ICD combines features of the transvenous and subcutaneous designs. Like the S-ICD, it avoids the transvenous lead and the lead-in-the-bloodstream complications. Unlike the S-ICD, it can deliver anti-tachycardia pacing because the lead is closer to the heart. It can also deliver short-term backup pacing, though it's not designed for chronic bradycardia pacing. Early experience suggests it's a viable option for patients who would otherwise be considered for an S-ICD but who'd benefit from ATP capability.

CRT and CRT-D

Cardiac resynchronization therapy (CRT) is a different concept layered on top of pacing. In patients with heart failure with reduced ejection fraction (HFrEF) and a wide QRS complex (especially left bundle branch block), the right and left ventricles contract out of sync. The dyssynchrony reduces pumping efficiency and worsens heart failure.

CRT addresses the dyssynchrony by adding a third lead in a branch of the coronary sinus on the lateral wall of the left ventricle. The device paces both ventricles simultaneously, restoring synchronous contraction. The COMPANION and CARE-HF trials established that CRT improves symptoms, reduces hospitalization, and reduces mortality in appropriately selected patients. MADIT-CRT extended this to less symptomatic patients with similar conduction findings.

The patients who benefit most have HFrEF with EF 35 percent or below, NYHA class II to ambulatory class IV symptoms despite optimal medical therapy, sinus rhythm, and a wide QRS (typically 150 ms or more, especially with LBBB morphology). Patients with QRS less than 130 ms tend not to benefit.

CRT can be delivered as CRT-P (pacemaker version, no defibrillator) or CRT-D (adds ICD function). Most CRT patients have HFrEF severe enough to also meet ICD criteria for primary prevention, so CRT-D is the more common choice. CRT-P is used for older or sicker patients where the goal is symptom improvement and the mortality benefit of a defibrillator is less applicable.

Combined Functions

CRT-D is the most common combined-function device. It's a CRT pacemaker with biventricular pacing, and it's also an ICD that can detect and treat ventricular arrhythmias. The patient with HFrEF, LBBB, and severe systolic dysfunction often needs all three: pacing for synchrony, sensing for arrhythmias, and shock capability.

A dual-chamber ICD is a more basic combined device: a pacemaker with atrial and ventricular leads, with the ventricular lead also functioning as a defibrillator. Patients who have AV block plus an indication for an ICD get this configuration. Single-chamber ICDs (one lead in the right ventricle) are used in patients who don't need atrial pacing. From the outside, the device on a chest X-ray looks similar regardless of which combination it is. The differences are in what the device can do, determined by the leads attached and the generator's programming.

What It Feels Like Day to Day

Pacing is imperceptible. Patients with pacemakers usually can't tell when their device is pacing versus when their own rhythm is firing. The pulse is small and timed in a way that doesn't trigger conscious awareness. Some patients notice a pectoral muscle twitch if there's lead displacement or high pacing thresholds, but this is uncommon and a sign to call the device clinic.

An ICD shock is the opposite. It's a strong jolt, often described as being kicked in the chest by a horse. It happens fast (the shock itself is milliseconds), but the experience is memorable. Many patients have anxiety about future shocks, which is normal and often improves with time and counseling. For patients with frequent shocks, antiarrhythmic medication and sometimes VT ablation are added to reduce shock burden. Anti-tachycardia pacing, by contrast, is usually felt as a brief fluttery sensation in the chest, much less dramatic than a shock.

The Procedure

Pacemaker and ICD implantation is typically done as outpatient or with an overnight stay. The patient gets conscious sedation or light general anesthesia. The implant area (left chest below the collarbone) is sterilized and numbed. A small incision is made, and a pocket is created under the skin or pectoral muscle. Leads are inserted through the subclavian or axillary vein under fluoroscopic guidance, positioned in the appropriate cardiac chambers, tested, and secured. The generator is connected to the leads and placed in the pocket.

The whole procedure takes 1 to 3 hours depending on complexity. CRT implantation takes longer because the coronary sinus lead placement is technically challenging. Most patients go home the same day or the next morning. The arm on the implant side is restricted from overhead reaching for several weeks to allow lead anchoring to mature. Heavy lifting and aggressive exercise are restricted for a similar period.

Living with the Device

Modern devices come with home monitoring. A bedside transmitter or a smartphone app communicates with the device wirelessly and uploads data to the device clinic regularly. Concerning events (arrhythmias, lead issues, battery changes) trigger automatic alerts. Patients are typically seen in clinic every 6 to 12 months for in-person device interrogation, with home monitoring filling in between visits.

MRI compatibility has improved dramatically. Most modern devices are MRI-conditional, meaning MRI scans can be performed safely with appropriate device programming during the scan. Older devices may not be MRI-compatible, and patients with those should check with their device clinic before any planned MRI.

Driving restrictions apply after ICD shocks. Standard recommendations say patients shouldn't drive private vehicles for several months after a sustained ventricular arrhythmia event treated by the ICD, with longer restrictions for commercial drivers. After uncomplicated implantation without prior arrhythmic events, driving restrictions are usually limited to the first week or two of recovery.

Devices interact with strong magnetic fields predictably. Patients should avoid prolonged contact with strong magnets, hold cell phones to the ear opposite the device, and walk through airport security without lingering. Most household electronics are fine.

Battery Life and Replacement

Pacemaker batteries typically last 8 to 15 years depending on how much pacing is required. ICD batteries last 5 to 10 years, with shocks consuming much more energy than pacing. CRT-D batteries are similar to ICD batteries.

When the battery reaches its replacement indicator, a generator change is performed. The original pocket is reopened, the old generator is removed, the leads are tested, and a new generator is connected. Leads usually stay in place; lead replacement is only done if a lead has failed. A generator change is shorter and less complex than the original implant.

Leadless pacemakers don't get replaced through a pocket because there isn't one. When the battery depletes, a second leadless device is implanted alongside the first, and the old device is left in place.

Risks

Implantation has a small but real risk profile. Pneumothorax (collapsed lung from subclavian vein access) occurs in about 1 percent of cases, sometimes requiring chest tube placement. Cardiac perforation by the lead is rare but serious. Pocket hematoma is more common, especially in patients on anticoagulation, and usually resolves with conservative management.

Lead-related complications develop over time. Lead fracture or insulation breakdown can cause inappropriate shocks (in ICDs) or loss of capture. Lead dislodgment in the first weeks after implant requires repositioning. Lead infection that tracks into the bloodstream is one of the most serious device complications and often requires complete system extraction.

Inappropriate shocks are a feared complication of ICDs. They occur when the device misclassifies a non-life-threatening rhythm (rapid AFib, sinus tachycardia, SVT) as VT or VF. Modern ICDs have sophisticated discrimination algorithms that have reduced inappropriate shock rates, but the rate is still in the low single digits per year of follow-up. Pocket erosion, where the generator becomes prominent under the skin, is uncommon but requires intervention.

Common Patient Questions

Will my device shock me?

If you have a pacemaker, no. Pacemakers don't deliver shocks. If you have an ICD or a CRT-D, yes, the device can shock you when it detects a dangerous rhythm. The shock is a feature, not a malfunction. It's designed to save your life when your heart goes into VT or VF.

Why did I get a pacemaker instead of an ICD (or vice versa)?

The choice depends on the rhythm problem we're solving. If your problem is slow heart rate or heart block, a pacemaker is the right device. If your problem is risk of sudden cardiac death from ventricular arrhythmias, an ICD is the right device. If you have both problems, you'd get a device that does both. Your cardiologist can pull up your records and walk you through exactly why your specific device was chosen.

Do I need both a pacemaker and an ICD?

If you need both functions, you don't need two separate devices. Every ICD includes pacemaker capability. So a patient with both heart block and a primary prevention indication for an ICD gets a single ICD that also paces.

Can I have an MRI with my device?

Most modern devices are MRI-conditional, meaning MRI is safe with specific precautions during the scan. Your device clinic can confirm your specific model and provide an MRI card. Older devices (pre-2010 in many cases) may not be MRI-compatible. Always tell the radiology team about your device before any MRI.

What happens if my battery runs out?

Devices warn you before the battery depletes. Home monitoring tracks battery status, and your device clinic schedules a generator change well before the battery actually runs out. The replacement procedure is shorter and simpler than the original implant.

Can I exercise normally?

Yes, after the initial healing period (typically 4 to 6 weeks of activity restriction). After that, most patients return to normal exercise, including running, swimming, weight training, and most sports. Contact sports with risk of direct chest impact (football, hockey, rugby) require discussion with your cardiologist. Devices respond to exercise by adjusting pacing rates appropriately.

What if I get shocked?

Sit or lie down somewhere safe. If you feel okay after a single shock, call your cardiology office the same day for guidance. If you have multiple shocks in a row, ongoing chest pain, or severe symptoms, call 911. After a shock, the device team will check the device to confirm the shock was appropriate and assess for triggers like medication non-adherence, electrolyte issues, or progression of underlying disease.

Will airport security or store anti-theft systems trigger my device?

Walking through normal airport metal detectors and store anti-theft systems is fine. You can show your device card to TSA if you want to bypass the metal detector. Don't linger in or near these systems. Most other electronic devices in normal use are not a concern.

When to Escalate Care

Call 911 immediately for multiple ICD shocks in rapid succession (electrical storm), severe chest pain, severe shortness of breath, syncope, or signs of stroke. Multiple shocks usually reflect a serious underlying arrhythmia situation that needs hospital management.

Contact your cardiologist or device clinic the same day for a single ICD shock without ongoing symptoms, new pocket pain or swelling, redness or drainage from the incision, fever after recent implant, or new symptoms suggesting device malfunction (palpitations, lightheadedness, fatigue out of proportion to baseline).

Schedule a clinic visit for routine device check intervals (every 6 to 12 months in most cases), questions about activity or travel, MRI planning, or non-urgent questions about your specific device and its capabilities.

A Final Note From Me

Pacemakers and ICDs treat opposite problems. A pacemaker is a backup for slow rhythms; an ICD is a rescue for fast rhythms. The confusion is understandable because they look similar from the outside, but the indications are distinct and the experiences of living with them differ. If you have a pacemaker, you'll likely never feel the device working. If you have an ICD, you may go years without it firing, and if it does fire, you'll know.

If you're trying to figure out which device you have or which one your cardiologist is recommending, the right starting question is what rhythm problem the device is meant to address. From there, the device choice follows logically. The newer options like leadless pacemakers, S-ICDs, and EV-ICDs add real benefits for patients who fit those niches. Talking through the trade-offs with your cardiologist before implant is worth the time.

If you already have a device and you're working out how to live with it, the people who do best are the ones who stay engaged with their device clinic, follow up on home monitoring alerts, treat the modifiable risk factors that influence arrhythmia burden (heart failure management, ischemia control, electrolyte stability), and understand what the device can and can't do. A device is a tool, not a cure. The underlying disease still matters, and so does the partnership with your cardiology team.

References

1. Moss, Arthur J., Wojciech Zareba, W. Jackson Hall, et al. "Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction." New England Journal of Medicine 346, no. 12 (2002): 877-883.

2. Bardy, Gust H., Kerry L. Lee, Daniel B. Mark, et al. "Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure." New England Journal of Medicine 352, no. 3 (2005): 225-237.

3. Kober, Lars, Jens J. Thune, Jens C. Nielsen, et al. "Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure." New England Journal of Medicine 375, no. 13 (2016): 1221-1230.

4. Bristow, Michael R., Leslie A. Saxon, John Boehmer, et al. "Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure." New England Journal of Medicine 350, no. 21 (2004): 2140-2150.

5. Cleland, John G. F., Jean-Claude Daubert, Erland Erdmann, et al. "The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure." New England Journal of Medicine 352, no. 15 (2005): 1539-1549.

6. Moss, Arthur J., W. Jackson Hall, David S. Cannom, et al. "Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events." New England Journal of Medicine 361, no. 14 (2009): 1329-1338.

7. Kusumoto, Fred M., Mark H. Schoenfeld, Coletta Barrett, et al. "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay." Circulation 140, no. 8 (2019): e382-e482.

8. Al-Khatib, Sana M., William G. Stevenson, Michael J. Ackerman, et al. "2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death." Circulation 138, no. 13 (2018): e272-e391.

9. Reynolds, Dwight, Gabor Z. Duray, Razali Omar, et al. "A Leadless Intracardiac Transcatheter Pacing System." New England Journal of Medicine 374, no. 6 (2016): 533-541.

10. Weiss, Raul, Bradley P. Knight, Michael R. Gold, et al. "Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator." Circulation 128, no. 9 (2013): 944-953.

Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.